The day's chaotic price action reinforces the cutthroat nature of the current tape.
We'll use gains to help fund our latest oil position.
Please note that the most recent purchase is Goldman Sachs, not General Electric
We will add to four holdings and add a new position in Marathon Oil.
This hedge protects against near-term weakness in IBM below the unchanged mark on the year.
It is one of the few attractively-valued biotech companies that already produces impressive results.
We're keeping a stop at the stock's previous highs, and we'll close our position on any moves lower.
Earnings topped estimates, and shares are climbing on the news.
Importantly, the company hasn't suffered much impact from the vehicle-recall issue.
The stock has lagged its peers, but the company is taking constructive steps.